Cargando…
De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer
Current adjuvant treatment guidelines for oropharyngeal squamous cell carcinoma treated with primary surgery are based on studies that predate the human papillomavirus (HPV) era. HPV-associated oropharynx carcinoma (HPV-OPC) has a much more favorable prognosis compared to HPV-unassociated cancer and...
Autores principales: | An, Yi, Holsinger, F. Christopher, Husain, Zain A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460758/ https://www.ncbi.nlm.nih.gov/pubmed/31093347 http://dx.doi.org/10.1186/s41199-016-0016-7 |
Ejemplares similares
-
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy
por: Taku, Nicolette, et al.
Publicado: (2021) -
Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
por: Morand, Grégoire B., et al.
Publicado: (2022) -
Oropharyngeal Cancer Epidemic and Human Papillomavirus
por: Ramqvist, Torbjörn, et al.
Publicado: (2010) -
De-intensification for HPV positive oropharyngeal cancer: and yet it moves!: 2019 in review
por: Bonomo, Pierluigi, et al.
Publicado: (2020) -
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
por: Zeng, Peter Y.F., et al.
Publicado: (2022)